FA
ABBV icon

FSA Advisors’s AbbVie ABBV Stock Holding History

FSA Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$851K Buy
3,382
+813
+32% +$175K 0.39% 80
2026
Q1 		$559K Sell
2,569
-9,509
-79% -$2.11M 0.37% 83
2025
Q4 		$520K Buy
12,078
+9,972
+474% +$2.27M 0.36% 83
2025
Q3 		$488K Buy
2,106
+1,027
+95% +$209K 0.39% 77
2025
Q2 		$200K Sell
1,079
-14
-1% -$2.6K 0.16% 171
2025
Q1 		$229K Buy
+1,093
New +$212K 0.18% 157

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FSA Advisors's ABBV Position: Q2 2026 in Review

FSA Advisors increased its AbbVie (ABBV) stake by 32% in Q2 2026, buying an estimated $175K and bringing the position to 3,382 shares worth $851K. The position accounts for 0.39% of the portfolio, ranked #80.

FSA Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FSA Advisors held 3,382 shares of AbbVie worth $851K as of Q2 2026.
  • FSA Advisors bought 813 AbbVie shares in Q2 2026, an estimated $175K.
  • AbbVie made up 0.39% of FSA Advisors's portfolio in Q2 2026, its #80 holding.
  • FSA Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.